Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

492
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
492
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

268
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
268
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

599
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
599
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

319
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
319
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

855
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
855
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.8K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Xpert MTB/XDR and Deeplex Myc-TB for the Rapid Detection of Drug Resistance in <i>Mycobacterium tuberculosis</i>.

International journal of microbiology·2026
Same author

Implementing shorter all-oral treatment durations for multidrug-resistant tuberculosis in the UK: from concept to application.

BMJ open respiratory research·2026
Same author

Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemic.

BMJ open·2026
Same author

Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort study.

The Journal of infection·2025
Same author

Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75-79 years in England: a multicentre, test-negative, case-control study.

The Lancet. Infectious diseases·2025
Same author

Why are we failing to rapidly diagnose tuberculosis in the UK?

Lancet (London, England)·2025
Same journal

Post-extubation pneumothorax following bougie-assisted endotracheal tube exchange.

BMJ case reports·2026
Same journal

Cardiac tamponade secondary to hypothyroidism.

BMJ case reports·2026
Same journal

Unmasking a rare contrast reaction: acute non-cardiogenic pulmonary oedema after iohexol injection.

BMJ case reports·2026
Same journal

Water gonioscopy-assisted transluminaltrabeculotomy.

BMJ case reports·2026
Same journal

<i>Clostridioides difficile</i> osteomyelitis presenting as a Brodie's abscess of the tibia.

BMJ case reports·2026
Same journal

Steroid refractory rapidly progressing organising pneumonia.

BMJ case reports·2026
See all related articles

Related Experiment Video

Updated: Nov 15, 2025

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases &#8212; Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.3K

When to consider tuberculosis: bronchiectasis in the elderly population.

Caitlin Rose Morgan1, Georgina K Russell2, Onn Min Kon2

  • 1Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK caitlin.morgan@doctors.org.uk.

BMJ Case Reports
|March 5, 2021
PubMed
Summary
This summary is machine-generated.

Older adults in England face over 4-month delays for pulmonary tuberculosis (TB) diagnosis. This delay, often due to atypical symptoms and pre-existing lung conditions like bronchiectasis, impacts timely treatment initiation.

Keywords:
TB and other respiratory infectionsglobal healthlong term caretuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.0K

Related Experiment Videos

Last Updated: Nov 15, 2025

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases &#8212; Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.3K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.0K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Geriatrics

Background:

  • Pulmonary tuberculosis (TB) diagnosis in patients aged 65+ in England is significantly delayed.
  • Average delay exceeds 4 months from symptom onset to diagnosis.
  • This impacts effective treatment and patient outcomes.

Observation:

  • This report details three cases of elderly patients with pulmonary TB.
  • All cases involved significant delays in both diagnosis and treatment.
  • Each patient had a history of bronchiectasis, complicating initial symptom assessment.

Findings:

  • Symptoms were initially misattributed to pre-existing lung conditions, such as bronchiectasis.
  • Factors contributing to diagnostic delays include immunosenescence, atypical TB presentation in the elderly, and pre-existing lung disease.
  • Delays occur at both primary care and specialist levels.

Implications:

  • Delayed diagnosis and treatment of pulmonary TB in older adults can lead to poorer prognoses.
  • Healthcare providers need increased awareness of atypical TB presentations in geriatric populations.
  • Strategies to shorten diagnostic timelines for pulmonary TB in the elderly are crucial.